Shrewsbury, Stephen B. http://orcid.org/0000-0001-9892-3695
Funding for this research was provided by:
Impel Pharmaceuticals
Article History
Accepted: 19 July 2023
First Online: 3 August 2023
Declarations
:
: STOP 101 [CitationRef removed], STOP 301 [CitationRef removed] and SNAP101 [CitationRef removed] were fully funded by Impel Pharmaceuticals.
: Dr Stephen B. Shrewsbury was Chief Medical Officer to Impel Pharmaceuticals at the time the above studies were conducted and during the initial development of this manuscript, but not during the subsequent review and revision process.
: Data sharing is not applicable to this article as no datasets were generated or analyzed for this manuscript. Some of the INP107-201 data have not been previously shared.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: This work was written by Dr. Stephen B. Shrewsbury with no additional contributions. However it has been through a series of internal reviews at Impel Pharmaceuticals and minor comments and edits incorporated.